SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros ($OMER) is trending due to a recent licensing deal with Novo Nordisk potentially worth billions, sparking excitement among investors. The community is actively discussing the deal's implications, possible price targets, and the potential for a short squeeze. Attention is also turning to other biotech stocks, with some mentioning TLPH as a company to watch.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is seeing intense debate as the stock trends downwards, with bears highlighting concerns about its valuation and potential dilution, while bulls remain optimistic. Community members are actively discussing short positions, potential squeezes, and the company's long-term prospects in the quantum computing sector amid Cramer's call to rotate out of hype names. Some traders are betting against the stock through inverse ETFs.

HCM II Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 4, 2024 and is headquartered in Stamford, CT.

HCM II Acquisition Corp - Ordinary Shares - Class A

HCM II Acquisition Corp.

HCM II Acquisition Corp. ($HOND) is trending due to its upcoming merger with Terrestrial Energy, a molten salt nuclear reactor developer, scheduled for an October vote. The community is actively discussing the potential for significant gains, comparing it to other nuclear plays like $OKLO, and speculating on post-merger performance. There's also discussion around warrant pricing and potential government support.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Fueled by backing from Sam Altman and broader interest in nuclear energy, Oklo ($OKLO) is trending as retail investors speculate on its potential in AI data centers. Community members are debating the stock's valuation, revenue timeline, and potential regulatory hurdles, with some highlighting the risks while others remain bullish on its long-term prospects in the energy sector.

Terra Innovatum Global NV operates as a holding company. It engages in the development of nuclear micro modular solutions focused on clean energy. The company was founded by Alessandro Petruzzi, Marco Cherubini, and Cesare Frepoli on April 27, 2025 and is headquartered in Lucca, Italy.

Terra Innovatum Global N.V.

Terra Innovatum Global N.V. Ordinary shares

Terra Innovatum ($NKLR) is trending as the GSRT merger finalizes, and traders are closely watching the stock's performance in the burgeoning small modular reactor (SMR) sector. Community members highlight the potential for growth, drawing comparisons to sector peers, while noting the company's Nasdaq debut and planned bell-ringing event may bring more attention. The focus remains on the perceived undervaluation relative to other nuclear plays and the potential impact of increasing demand for nuclear energy.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ ($LAES) is trending due to a recently announced $200M securities offering, sparking mixed reactions from investors; while some express concerns about dilution and potential financial instability, others view it as a strategic move to fuel growth in the quantum computing sector. Community discussions revolve around the offering's impact on share value, the company's long-term prospects, and the potential for a short squeeze. The stock's volatility is attracting attention as investors debate whether to buy the dip or exit their positions.

Microvast Holdings, Inc. is an advanced battery technology company. It engages in the business of designing, developing, and manufacturing battery components and systems primarily for electric commercial vehicles and utility-scale energy storage systems. The company was founded by Yang Wu on October 12, 2006 and is headquartered in Stafford, TX.

Microvast Holdings Inc

Microvast ($MVST) is trending due to community excitement around its potential for growth, driven by a small float, low short interest, and progress in EU revenues. Community members believe the stock is undervalued compared to competitors and anticipate a move towards higher valuations, with some eyeing a potential short squeeze and bullish technical indicators, as well as upcoming Q3 earnings, further fueling optimism.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending as investors anticipate a potential gamma squeeze and celebrate breaking the $40 mark, fueled by ongoing excitement around data center and AI infrastructure plays. Community members are actively discussing the possibility of securing new deals with investment-grade hyperscalers. The stock's movement is occurring even as the broader market faces downward pressure, adding to the bullish sentiment.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

ABAT is trending due to a recent surge, prompting discussions about profit-taking, short squeezes, and the company's long-term potential in battery technology. The community is actively debating whether the stock will continue its upward trajectory or experience a pullback, with some pointing to potential catalysts like government funding and the release of a Pre-Feasibility Study (PFS). Speculation is rising with some comparing it to other high growth stocks in the sector.

Sadot Group, Inc. operates as a restaurant chain business. It operates through the following segments: Muscle Maker Grill Restaurant, Pokemoto Hawaiian Poke Restaurant, Non-Traditional (Hybrid), SuperFit Foods Meal Prep, and Sadot. The firm offers protein- based meals featuring chicken, seafood, pasta, hamburgers, wraps and flat breads. It also provides salads, protein shakes and fruit smoothies. The company was founded by Rodney C. Silva in 2022 and is headquartered in Burleson, TX.

Sadot Group Inc

SDOT is trending due to speculative interest in agriculture and oilseed stocks, possibly fueled by political rhetoric about cooking oil supply chains. The community is actively discussing the company's low float and potential for a short squeeze, alongside anticipation for news regarding the restaurant sale and the company's crypto treasury strategy. Some traders express concerns over previous dilution and reverse splits, while others maintain a bullish outlook based on revenue and potential catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MindMed Announces New Employee Inducement Grant

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today...

Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?

Here is how ANIXA BIOSCIENCES INC (ANIX) and Mind Medicine (MindMed) Inc. (MNMD) have performed compared to their sector so far this year.

All You Need to Know About Mind Medicine MindMed (MNMD) Rating Upgrade to Buy

Mind Medicine MindMed (MNMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Wall Street Analysts Believe Mind Medicine MindMed (MNMD) Could Rally 237.47%: Here's is How to Trade

Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect?

Shares of Mind Medicine Inc. climbed 3.6% on Thursday and extended gains after hours, with retail sentiment improving following the company's fourth-quarter earnings report.The psychedelics treatment developer reported a net loss of $34.7 million for the quarter ended Dec. 31, 2024, widening from a $23.8 million loss a year earlier, largely due to higher research and development costs tied to its MM120 and MM402 programs.&nbsp;MM120, MindMed's lead drug candidate, is designed to treat generalized anxiety disorder (GAD), while MM402 is being developed to address core symptoms of Autism Spectrum Disorder (ASD).However, the company's adjusted Q4 loss per share of $0.41 narrowed from $0.59 a year ago, though it missed analyst expectations of a $0.28 loss.CEO Rob Barrow remained upbeat, stating that 2024 was a "year of significant progress" and that the company had achieved key milestones leading into multiple Phase 3 clinical readouts for MM120, which he expects to drive MindMed's next growth phase.On Stocktwits, sentiment for MNMD shifted from 'bearish' to 'neutral' in the 24 hours leading up to Thursday, with message volume surging 250%.<figure class="image"><img style="aspect-ratio:1316/302;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/MNMD_sentiment_and_message_volume_as_of_March_6_8b8a5ebcbf.png" alt="MNMD sentiment and message volume as of March 6.png" width="1316" height="302"><figcaption>MNMD sentiment and message volume as of March 6 | source: Stocktwits</figcaption></figure>One user expressed confidence in MM120's potential, saying, "Once Phase 3 [of the MM120 study] passes, this is going to blow up."<stembedurl>https://stocktwits.com/Bball4/message/606995440</stembedurl>Another key factor boosting optimism was MindMed's strong cash reserves. The company ended 2024 with $273.7 million in cash and cash equivalents, up from $99.7 million a year earlier, which the company expects to be sufficient to support operations into 2027.One user wrote, "We won't have to do any more reverse splits. MNMD has cash reserves until approvals."<stembedurl>https://stocktwits.com/BullsVSBearsVSYoMomma/message/607108323</stembedurl>Additionally, traders pointed to potential government&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/mnmd-stock-soars-after-rfk-jr-confirmed-as-hhs-chief/ch5iJvpRH6">support</a> under new Health and Human Services chief Robert F. Kennedy Jr., who has previously advocated for the decriminalization of psychedelics for therapeutic use.The company also plans regulatory and pre-commercialization activities for MM120's orally disintegrating tablet (ODT) version.One watcher pointed out that although MNMD lags behind competitor Compass Pathways in clinical progress, its broader drug pipeline gives it an edge.Mind Medicine shares remain down over 7% year-to-date but have gained over 10% in the past 12 months.&nbsp;According to Koyfin, of the 11 analysts covering the stock, seven rate it a 'buy,' while four have a 'strong buy' rating.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Mind Medicine's Net Losses Swell In Q4, But Retail Finds At Least 3 Reasons To Stay Bullish

The psychedelics treatment developer reported a net loss of $34.7 million for the quarter ended Dec. 31, 2024, widening from a $23.8 million loss a year earlier.

Equity

The psychedelics treatment developer reported a net loss of $34.7 million for the quarter ended Dec. 31, 2024, widening from a $23.8 million loss a year earlier.


MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the 'Company' or 'MindMed'), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today...

Shares of Mind Medicine Inc. (MNMD) surged more than 15% Friday afternoon, on track for their best session since April 2024, as retail traders cheered Robert F. Kennedy Jr.’s confirmation as U.S. Health and Human Services secretary.The stock is now set to post weekly gains of over 22%, its strongest performance since the week of Donald Trump’s 2024 election victory in November.&nbsp;<figure class="image"><img style="aspect-ratio:1318/324;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/MNMD_sentiment_Feb_14_dada4484f8.png" alt="MNMD sentiment Feb 14.png" width="1318" height="324"><figcaption>MNMD sentiment Feb 14 as of 2:30 pm ET | source: Stocktwits</figcaption></figure>On Stocktwits, sentiment turned even more bullish, with message volume skyrocketing 720% in the past three months amid RFK Jr.’s rise to the cabinet.“The RFK bump,” one user wrote, echoing several other posts, while another predicted a “big breakout” next week.&nbsp;<stembedurl>https://stocktwits.com/mpferd/message/604362153</stembedurl><stembedurl>https://stocktwits.com/Knot2/message/604306853</stembedurl>Kennedy has previously&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/livecoverage/trump-cabinet-confirmation-hearings/card/what-has-rfk-jr-said-about-weight-loss-drugs-antidepressants-and-psychedelics--eAaDAxA6vQaSVMeBPlEs">advocated</a> for decriminalizing psychedelics for therapeutic use, citing his son’s positive experience with the hallucinogenic brew ayahuasca.Wall Street has also taken notice.&nbsp;Earlier this month, Chardan named Mind Medicine as a top biotech pick for 2025, citing strong Phase 2 results for its lead drug candidate MM120, which targets generalized anxiety disorder (GAD).&nbsp;The research firm has a ‘Buy’ rating with a $20 price target — implying a doubling from current levels — and projects potential MM120 peak sales of over $1 billion by 2026.In January, Evercore ISI <a href="https://stocktwits.com/news-articles/markets/equity/mnmd-stock-rises-on-evercore-isi-rating/chbVQU4RYM">initiated</a> coverage with an ‘Outperform’ rating and a $23 target, highlighting Mind Medicine’s innovative oral LSD formulation and its potential in treating both GAD and major depressive disorder (MDD).Still, not everyone’s betting on more gains. Short interest has climbed from 12.9% at the start of the year to 14.2% by January’s end, per Koyfin data.<a href="https://stocktwits.com/symbol/MNMD">Mind Medicine shares</a> have gained over 42% year-to-date, outperforming Compass Pathways but lagging Atai Life Sciences’ 79% surge. Those two companies are also developing psychedelic therapeutics.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Robert F. Kennedy Jr. speaks after being sworn in as Secretary of Health and Human Services in the Oval Office at the White House on February 13, 2025 in Washington, DC. (Photo by Andrew Harnik/Getty Images)

Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months

Kennedy has previously advocated for decriminalizing psychedelics for therapeutic use, citing his son’s positive experience with the hallucinogenic brew ayahuasca.

MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the Company or MindMed), a late-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that...

MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the 'Company' or 'MindMed'), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today...

Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Mind Medicine Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

MNMD
Mind Medicine Inc - Ordinary Shares (Sub Voting)

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MNMD News

MNMDMind Medicine Inc - Ordinary Shares (Sub Voting)